Breaking News Instant updates and real-time market news.

EMHTF

Emerald Health Therapeutics

$0.00 /

+ (+0.00%)

07:20
08/29/19
08/29
07:20
08/29/19
07:20

Emerald Health Therapeutics reports Q2 revenue $5.07M vs. $282,462 last year

Net loss per common share was 0.3c, compared to 4.3c in 1Q19. "Emerald is strategically positioned to be a leader in the cannabis industry. As we enter the second half of 2019, we will focus our efforts on refining our business model and scaling our operations to fully leverage and further enable the success of our PSF JV while sharpening our own business strategy, operations and core areas of business. We will complete the build out and licensing of our two other 100%-owned facilities, allowing them to become revenue generating in 2020, enhance our brand, as well as our targeted research efforts in novel, proprietary product development, and continue to build on value-added strategic partnerships to enhance profitability, speed up market entry, or provide enhanced expertise in specific areas," said Riaz Bandali, Chief Executive Officer of Emerald. "We believe that these actions will enhance and clearly differentiate our competitive position in the marketplace, while concurrently allowing us to refine our operational model and move towards enhanced and sustained profitability in the future."

  • 29

    Aug

EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

02/25/19 JEFF
Emerald Health Therapeutics initiated with a Hold at Jefferies
02/25/19
Fly Intel: Top five analyst initiations

TODAY'S FREE FLY STORIES

Upgrade
S&P Global upgraded to Outperform from Market Perform at BMO Capital » 07:22
01/27/20
01/27
07:22
01/27/20
07:22
SPGI

S&P Global

$294.82 /

-2.51 (-0.84%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Chewy upgraded to Outperform at Wedbush on online pet industry sales growth » 07:21
01/27/20
01/27
07:21
01/27/20
07:21
CHWY

Chewy

$28.48 /

+0.41 (+1.46%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
IHS Markit downgraded to Market Perform from Outperform at BMO Capital » 07:20
01/27/20
01/27
07:20
01/27/20
07:20
INFO

IHS Markit

$79.89 /

-0.7 (-0.87%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Intelligent Systems initiated with a Buy at BTIG » 07:19
01/27/20
01/27
07:19
01/27/20
07:19
INS

Intelligent Systems

$40.39 /

+0.35 (+0.87%)

, AAPL

Apple

$318.25 /

-1.02 (-0.32%)

BTIG analyst Mark Palmer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Halozyme price target raised to $35 from $27 at Cantor Fitzgerald » 07:18
01/27/20
01/27
07:18
01/27/20
07:18
HALO

Halozyme

$19.07 /

-0.58 (-2.95%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Sorrento Therapeutics to present clinical trial data for resiniferatoxin » 07:18
01/27/20
01/27
07:18
01/27/20
07:18
SRNE

Sorrento Therapeutics

$4.29 /

+0.105 (+2.51%)

Sorrento Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Target 12% pullback 'key buying opportunity,' says JPMorgan » 07:16
01/27/20
01/27
07:16
01/27/20
07:16
TGT

Target

$114.31 /

-1.23 (-1.06%)

JPMorgan analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
RedHill Biopharma on track to launch Talicia in the U.S. in 1Q20 » 07:15
01/27/20
01/27
07:15
01/27/20
07:15
RDHL

RedHill Biopharma

$5.96 /

-0.045 (-0.75%)

RedHill Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Northland downgrades SolarEdge on expectation for slowing growth » 07:15
01/27/20
01/27
07:15
01/27/20
07:15
SEDG

SolarEdge

$110.13 /

+1.39 (+1.28%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
FX Update: Safe-have currencies rose » 07:15
01/27/20
01/27
07:15
01/27/20
07:15

FX Update: Safe-have…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Enthusiast Gaming graduates to the Toronto Stock Exchange » 07:14
01/27/20
01/27
07:14
01/27/20
07:14
ENGMF

Enthusiast Gaming

$0.00 /

+ (+0.00%)

Enthusiast Gaming…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Vivint Smart Home initiated with an Overweight at JPMorgan » 07:13
01/27/20
01/27
07:13
01/27/20
07:13
VVNT

Vivint Smart Home

$11.73 /

+0.01 (+0.09%)

JPMorgan analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
5G should drive modest return to Apple iPhone revenue growth, says Credit Suisse » 07:13
01/27/20
01/27
07:13
01/27/20
07:13
AAPL

Apple

$318.25 /

-1.02 (-0.32%)

Ahead of Apple's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Mattel initiated with an Overweight at JPMorgan » 07:12
01/27/20
01/27
07:12
01/27/20
07:12
MAT

Mattel

$14.27 /

-0.17 (-1.18%)

JPMorgan analyst Tami…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Kennedy Wilson initiated with a Neutral at BofA » 07:12
01/27/20
01/27
07:12
01/27/20
07:12
KW

Kennedy Wilson

$22.16 /

-0.32 (-1.42%)

BofA analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Hasbro initiated with a Neutral at JPMorgan » 07:12
01/27/20
01/27
07:12
01/27/20
07:12
HAS

Hasbro

$104.71 /

-0.71 (-0.67%)

JPMorgan analyst Tami…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Anavex achieves enrollment target for ANAVEX 2-73 Phase 2 PDD trial » 07:12
01/27/20
01/27
07:12
01/27/20
07:12
AVXL

Anavex

$2.92 /

-0.08 (-2.67%)

Anavex Life Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Synchrony price target lowered to $37 from $43 at BMO Capital » 07:11
01/27/20
01/27
07:11
01/27/20
07:11
SYF

Synchrony

$32.63 /

-3.56 (-9.84%)

BMO Capital analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Rexnord sees annual increases in common dividend amount » 07:09
01/27/20
01/27
07:09
01/27/20
07:09
RXN

Rexnord

$32.26 /

-0.42 (-1.29%)

Rexnord announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
NuCana announces first patients dosed in Phase III study of Acelarin » 07:09
01/27/20
01/27
07:09
01/27/20
07:09
NCNA

NuCana

$5.11 /

-0.025 (-0.49%)

NuCana announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Rexnord expands share repurchase authorization to $300M » 07:08
01/27/20
01/27
07:08
01/27/20
07:08
RXN

Rexnord

$32.26 /

-0.42 (-1.29%)

The Rexnord board…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
EyePoint, Ocumension sign exclusive license agreement for DEXYCU » 07:07
01/27/20
01/27
07:07
01/27/20
07:07
EYPT

EyePoint

$1.93 /

-0.06 (-3.02%)

EyePoint Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Kraft Heinz CEO wants to take fewer, but bigger bets on new products, WSJ says » 07:07
01/27/20
01/27
07:07
01/27/20
07:07
KHC

Kraft Heinz

$30.41 /

-0.29 (-0.94%)

Kraft Heinz CEO Miguel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Johnson & Johnson price target raised to $170 from $163 at Credit Suisse » 07:07
01/27/20
01/27
07:07
01/27/20
07:07
JNJ

Johnson & Johnson

$148.32 /

-0.27 (-0.18%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
AstraZeneca divests rights to established hypertension medicines » 07:07
01/27/20
01/27
07:07
01/27/20
07:07
AZN

AstraZeneca

$49.28 /

-0.93 (-1.85%)

AstraZeneca announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.